Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study
2009
Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease
2011
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome
2010
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
2009 Standout
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Breast cancer
2019 Standout
TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma
2016
Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy
2017
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
2008
Preoperative assessment of HER-2/neu status in breast carcinoma: The role of quantitative real-time PCR on core-biopsy specimens
2009
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials
2011 Standout
Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
2012
Prevalence of pain in patients with breast cancer post-treatment: A systematic review
2018
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Two-Color, Cytokeratin-Labeled DNA Flow Cytometric Analysis of 332 Breast Cancers
2001
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model
2008
Endometrial Carcinomas
2011
The Risk of Developing Arm Lymphedema Among Breast Cancer Survivors: A Meta-Analysis of Treatment Factors
2009
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Preoperative assessment enables the early diagnosis and successful treatment of lymphedema
2008
ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer
2010
Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection – data from a prospective randomised trial
2008
mRNA-based therapeutics — developing a new class of drugs
2014 StandoutNobel
Incidence and Time Path of Lymphedema in Sentinel Node Negative Breast Cancer Patients: A Systematic Review
2015
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
2010
Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment
2009
Levels of Circulating Cell-Free Nuclear and Mitochondrial DNA in Benign and Malignant Ovarian Tumors
2008
Morbidity of Sentinel Node Biopsy in Breast Cancer: The Relationship Between the Number of Excised Lymph Nodes and Lymphedema
2010
Short- and long-term recovery of upper limb function after axillary lymph node dissection
2009
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study
2012
Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue
2009
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
The post ACOSOG Z0011 era: Does our new understanding of breast cancer really change clinical practice?
2012
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial
2013
Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review
2011
Prognostic value of DNA cytometry in 281 premenopausal patients with lymph node negative breast carcinoma randomized in a control trial
2000
Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?
2011
Breast cancer related lymphedema in patients with different loco-regional treatments
2012
The Characterization of Human Amnion Epithelial and Mesenchymal Cells: the Cellular Expression, Activity and Glucocorticoid Regulation of Prostaglandin Output
2000
Interaction of tumor cells and lymphatic vessels in cancer progression
2011
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
2011
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Integrated genomic characterization of endometrial carcinoma
2013 StandoutNature
Prognostic Value of Ki67 Expression After Short-Term Presurgical Endocrine Therapy for Primary Breast Cancer
2007
Targeting apoptosis in cancer therapy
2020 Standout
A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer
2016
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Oxidative Stress in Cancer
2020 Standout
Morbidity of Sentinel Node Biopsy: Relationship Between Number of Excised Lymph Nodes and Patient Perceptions of Lymphedema
2011
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
2010 Standout
Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
2011 Standout
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time
2011
The CDK inhibitors in cancer research and therapy
2011
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
2013 Standout
Adherence to oral endocrine treatments in women with breast cancer: can it be improved?
2011
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy
2011
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations
2010
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010 Standout
Lymphedema beyond breast cancer
2010 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
Origins, structures, and functions of circulating DNA in oncology
2016
Burn injury
2020 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
2019 StandoutNobel
Persistent pain after lymph node excision in patients with malignant melanoma is neuropathic
2011
Time-Dependent and Organ-Specific Changes in Mitochondrial Function, Mitochondrial DNA Integrity, Oxidative Stress and Mononuclear Cell Infiltration in a Mouse Model of Burn Injury
2015
Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments
2018
Case-Control Study to Evaluate Predictors of Lymphedema After Breast Cancer Surgery
2009
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
2018 StandoutNobel
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements
2008
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.
2003
Circulating tumor cells: approaches to isolation and characterization
2011
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
2017 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors
2008
Cancer treatment and survivorship statistics, 2019
2019 Standout
Cancer Genome Landscapes
2013 StandoutScience
uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues
2006
Patient-Reported Outcomes in Sentinel Node–Negative Adjuvant Breast Cancer Patients Receiving Sentinel-Node Biopsy or Axillary Dissection: National Surgical Adjuvant Breast and Bowel Project Phase III Protocol B-32
2010
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Recent progress in the treatment and prevention of cancer‐related lymphedema
2014
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Short-Term Treadmill Running as a Model for Studying Cell-Free DNA Kinetics In Vivo
2011
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Edward Wight being referenced
Analysis of potential prognostic factors in 111 patients with ovarian cancer
2004
Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2
2005
Phosphorylation of tyrosine 1248-ERBB2 measured by chemiluminescence-linked immunoassay is an independent predictor of poor prognosis in primary breast cancer patients
2006
Increased Expression of Urokinase-Type Plasminogen Activator mRNA Determines Adverse Prognosis in ErbB2-Positive Primary Breast Cancer
2006
Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors
2009
Comparison of gene expression profiles in core biopsies and corresponding surgical breast cancer samples
2006
Metastatic patterns at autopsy in patients with ovarian carcinoma
2007
Prognostic impact and therapeutic implications of sentinel lymph node micro‐metastases in early‐stage breast cancer patients
2011
Elevated level of cell-free plasma DNA is associated with breast cancer
2007
Axillary Lymph Node Dissection for Sentinel Lymph Node Micrometastases May Be Safely Omitted in Early-Stage Breast Cancer Patients: Long-Term Outcomes of a Prospective Study
2009
Morbidity of Sentinel Lymph Node Biopsy (SLN) Alone Versus SLN and Completion Axillary Lymph Node Dissection After Breast Cancer Surgery
2007
PTEN as a Molecular Marker to Distinguish Metastatic From Primary Synchronous Endometrioid Carcinomas of the Ovary and Uterus
2003
Accuracy of frozen section of sentinel lymph nodes: a prospective analysis of 659 breast cancer patients of the Swiss multicenter study
2008
Premenopausal node-negative breast cancer: May adjuvant chemotherapy be indicated by the analysis of nuclear DNA dynamics?
1997
Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients
2008
Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer
2008
Chronic Blockade of Nitric OxideâSynthase and Endothelin Receptors During Pregnancy in the Rat: Effect on Pregnancy Outcome
1998
Levels of Circulating Cell-Free Serum DNA in Benign and Malignant Breast Lesions
2007
Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease.
2008